더말 필러 시장 : 유형별(히알루론산, Calcium Hydroxylapatite, 폴리 L 젖산, 기타), 성별, 서비스 프로바이더별 - 세계 기회 분석 및 산업 예측(2021-2031년)

The global dermal filler market was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.

The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.

Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.

The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.

However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.

The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

• Hyaluronic acid (HA)
  • Age group
  • 13 to 39
  • 40 to 54
  • 55 to 69
• Calcium Hydroxylapatite (CaHA)
• Poly L lactic Acid
• Others

By Gender

• Male
• Female

By Service Provider

• Specialty and Dermatology Clinics
• Hospitals
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest Of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • Colombia
  • Rest Of LAMEA
• Key Market Players
  • AbbVie Laboratories
  • Bioxis pharmaceutical
  • Cutera Inc
  • Elan aesthetics Inc
  • Galderma SA
  • Merz Pharma GmbH and Co. KGaA
  • Revance Therapeutics
  • Sinclair Pharma
  • Teoxane Laboratories
  • Vital Esthetique Laboratories

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market
• 3.7.Patent Landscape

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Hyaluronic acid (HA)
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
  • 4.2.4 Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 4.2.4.1 13 to 39 Market size and forecast, by region
    • 4.2.4.2 40 to 54 Market size and forecast, by region
    • 4.2.4.3 55 to 69 Market size and forecast, by region
• 4.3 Calcium Hydroxylapatite (CaHA)
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country
• 4.4 Poly L lactic Acid
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market analysis by country
• 4.5 Others
  • 4.5.1 Key market trends, growth factors and opportunities
  • 4.5.2 Market size and forecast, by region
  • 4.5.3 Market analysis by country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Male
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Female
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Specialty and Dermatology Clinics
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market analysis by country
• 6.3 Hospitals
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market analysis by country
• 6.4 Others
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market analysis by country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Type
    • 7.2.2.1 North America Hyaluronic acid (HA) Dermal Filler Market by Age group
  • 7.2.3 North America Market size and forecast, by Gender
  • 7.2.4 North America Market size and forecast, by Service Provider
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Market size and forecast, by Type
    • 7.2.5.1.2 Market size and forecast, by Gender
    • 7.2.5.1.3 Market size and forecast, by Service Provider
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Market size and forecast, by Type
    • 7.2.5.2.2 Market size and forecast, by Gender
    • 7.2.5.2.3 Market size and forecast, by Service Provider
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Market size and forecast, by Type
    • 7.2.5.3.2 Market size and forecast, by Gender
    • 7.2.5.3.3 Market size and forecast, by Service Provider
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.2.1 Europe Hyaluronic acid (HA) Dermal Filler Market by Age group
  • 7.3.3 Europe Market size and forecast, by Gender
  • 7.3.4 Europe Market size and forecast, by Service Provider
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Market size and forecast, by Type
    • 7.3.5.1.2 Market size and forecast, by Gender
    • 7.3.5.1.3 Market size and forecast, by Service Provider
    • 7.3.5.2 France
    • 7.3.5.2.1 Market size and forecast, by Type
    • 7.3.5.2.2 Market size and forecast, by Gender
    • 7.3.5.2.3 Market size and forecast, by Service Provider
    • 7.3.5.3 UK
    • 7.3.5.3.1 Market size and forecast, by Type
    • 7.3.5.3.2 Market size and forecast, by Gender
    • 7.3.5.3.3 Market size and forecast, by Service Provider
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Market size and forecast, by Type
    • 7.3.5.4.2 Market size and forecast, by Gender
    • 7.3.5.4.3 Market size and forecast, by Service Provider
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Market size and forecast, by Type
    • 7.3.5.5.2 Market size and forecast, by Gender
    • 7.3.5.5.3 Market size and forecast, by Service Provider
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Market size and forecast, by Type
    • 7.3.5.6.2 Market size and forecast, by Gender
    • 7.3.5.6.3 Market size and forecast, by Service Provider
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.2.1 Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group
  • 7.4.3 Asia-Pacific Market size and forecast, by Gender
  • 7.4.4 Asia-Pacific Market size and forecast, by Service Provider
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 China
    • 7.4.5.1.1 Market size and forecast, by Type
    • 7.4.5.1.2 Market size and forecast, by Gender
    • 7.4.5.1.3 Market size and forecast, by Service Provider
    • 7.4.5.2 Japan
    • 7.4.5.2.1 Market size and forecast, by Type
    • 7.4.5.2.2 Market size and forecast, by Gender
    • 7.4.5.2.3 Market size and forecast, by Service Provider
    • 7.4.5.3 India
    • 7.4.5.3.1 Market size and forecast, by Type
    • 7.4.5.3.2 Market size and forecast, by Gender
    • 7.4.5.3.3 Market size and forecast, by Service Provider
    • 7.4.5.4 Australia
    • 7.4.5.4.1 Market size and forecast, by Type
    • 7.4.5.4.2 Market size and forecast, by Gender
    • 7.4.5.4.3 Market size and forecast, by Service Provider
    • 7.4.5.5 Rest of Asia-Pacific
    • 7.4.5.5.1 Market size and forecast, by Type
    • 7.4.5.5.2 Market size and forecast, by Gender
    • 7.4.5.5.3 Market size and forecast, by Service Provider
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.2.1 LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group
  • 7.5.3 LAMEA Market size and forecast, by Gender
  • 7.5.4 LAMEA Market size and forecast, by Service Provider
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Market size and forecast, by Type
    • 7.5.5.1.2 Market size and forecast, by Gender
    • 7.5.5.1.3 Market size and forecast, by Service Provider
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Market size and forecast, by Type
    • 7.5.5.2.2 Market size and forecast, by Gender
    • 7.5.5.2.3 Market size and forecast, by Service Provider
    • 7.5.5.3 Colombia
    • 7.5.5.3.1 Market size and forecast, by Type
    • 7.5.5.3.2 Market size and forecast, by Gender
    • 7.5.5.3.3 Market size and forecast, by Service Provider
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Market size and forecast, by Type
    • 7.5.5.4.2 Market size and forecast, by Gender
    • 7.5.5.4.3 Market size and forecast, by Service Provider

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 AbbVie Laboratories
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 Bioxis pharmaceutical
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 Cutera Inc
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 Elan aesthetics Inc
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Galderma SA
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 Merz Pharma GmbH and Co. KGaA
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Revance Therapeutics
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Sinclair Pharma
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Teoxane Laboratories
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Vital Esthetique Laboratories
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments